SlideShare a Scribd company logo
The impact of rare
variation on gene
expression across tissues
Katia Lopes, PhD
Ricardo Vialle, PhD
Raj Lab
Department of Neurosciences
May 1st 2019
Background
Currently is hard to distinguish pathogenic from benign rare non-
coding variants
Association studies (like GWAS) usually works fine for common
variants, however they are not practical for rare variants (large
sample sizes are required)
Analyzing the effect of rare non-coding variants in the expression
across different tissues may help to elucidate their roles in
diseases!
GTEx project v6p release
RNA-seq + Whole-genome sequencing (WGS)
449 individuals
44 tissues
log2(RPKM + 2)
Allele-specific expression (ASE)
Gencode v.19 annotation
Protein coding genes + long intergenic noncoding RNAs (lincRNA)
Estimated hidden factors using PEER
Standardized the expression for each gene with Z-scores
Data
PEER correction
Total expression removed by PEER
A noticeable difference between the brain and other tissues ???
Linear Regression between the covariate values
and the PEER factors
White = missing values
Outlier definition
Focus: Individuals with extremely high or extremely low expression of
a particular gene compared with the population
OUTLIERS
|Z-score| >= 2
AKR1C4
Single-tissue outlier
Single-tissue outlier
Single-tissue outlier
Multi-tissue outlier
At least 5 tissues
For each gene… e.g.
Pair Gene + Individual
Multi-tissue outlier distribution
Ext Fig 2 - Distribution of the number of genes with a multi-tissue outlier.
a, Each individual was an outlier for a median of 10 genes. Individuals with 50 or more outliers
are colored in grey and were excluded from downstream analyses. b – c, Distribution of the
number of genes for which individuals, stratified by common covariates, were multi-tissue
outliers.
Number of genes
Multi-tissue outliers
GTEx
449 individuals
44 tissues
10 brain tissues
18,830 genes tested
b, Outlier expression sharing between
tissues measured by the proportion of
single-tissue outliers that have a |Z-
score| >= 2
Single tissue outlier
Replication of expression outliers
2 groups of expression data:
Discovery set of 34 tissues
Replication set of 10 tissues
For t = 10, 15, 20, 25 and 30
Multi-tissue outlier replication
Replication = 60% | Z-score >=1
Replication = ~30% | Z-score >=2
In order to investigate the influence of rare genetic variation on extreme
expression levels they focused on individuals of European ancestry with
WGS data (1,144 multi-tissue outliers)
Autosomal variants that passed all filters in the VCF (PASS in the filter
column)
Rare variants were defined as having MAF ≤ 0.01 in GTEx
SNVs and indels with MAF ≤ 0.01 in the European population of the 1000
Genomes Project Phase 3 data
They checked if the allele frequency was similar in the 1000 Genome Project
Rare genetic variation
Multi-tissue outliers were strongly enriched for nearby rare variants. The enrichment was most
pronounced for structural variants (SV) and greater for short insertions and deletions (indels)
than for single-nucleotide variants (SNVs)
Enrichment of rare variants in outliers
Figure 2 | Enrichment of rare variants and allele-specific expression (ASE) in outliers.
a, Enrichment within 10 kb of the transcription start site (TSS) among outliers.
Rare Common
1144 multi-tissue outlier
(WGS)
Y = Enrichment as the
relative risk of having a
nearby rare variant
Figure 2 | Enrichment of rare variants and allele-specific expression (ASE) in outliers.
b, Rare SNV enrichments at increasing Z-score thresholds.
Rare genetic variation
Under vs Over expressed outliers
Under vs Over expressed outliersAllele-specificexpression(ASE)
Figure 3 | Stratification of multi-tissue outliers by rare variant classes.
RIVER (RNA-informed variant effect on regulation)
A Bayesian statistical model that jointly analyses genome and transcriptome
data from the same individual to estimate the probability that a variant has
regulatory impact!
Software - RIVER
Roadmap Epigenomics
CADD
VEP
F = binary variable
representing the
functional regulatory
status of the rare variant
E = binary node
representing expression
outlier status
Software: RIVER
Figure 5 | Performance of RIVER for prioritizing functional regulatory variants.
b, Predictive power of RIVER compared to an L2-regularized logistic regression model using
only genomic annotations.
3.766 pairs shared by 2 individuals
Computes test posterior
probabilities of FR for 1st
individual, and compares them
with outlier status of 2nd
individual from the list
Software: RIVER
Figure 5 | Performance of RIVER for prioritizing functional regulatory variants.
c, Distribution of RIVER scores as a function of expression and genomic annotation scores.
ClinVar pathogenic variants
GAMT is associated with cerebral
creatine deficiency syndrome 2, and
causes neurological deficiencies and
also lead to low body fat
SBDS is associated with the
recessive Shwachman–Diamond
syndrome
Software: RIVER
Applications for Raj Lab
1. Correlate factors with covariates (PEER, PCA … )
2. Z-scores for gene-individual outlier detection
3. Enrichment of rare variants near outliers
4. Use RIVER to prioritize rare variants in each individual genome by their
predicted impact on gene expression
5. Single vs Multi-tissue data (or multi cell types?)

More Related Content

What's hot

Comparison of LUMPY vs. DELLY for structural variant detection
Comparison of LUMPY vs. DELLY for structural variant detectionComparison of LUMPY vs. DELLY for structural variant detection
Comparison of LUMPY vs. DELLY for structural variant detection
Ronak Shah
 
MAGIC :Multiparent advanced generation intercross and QTL discovery
MAGIC :Multiparent advanced generation intercross and  QTL discovery MAGIC :Multiparent advanced generation intercross and  QTL discovery
MAGIC :Multiparent advanced generation intercross and QTL discovery
Senthil Natesan
 
Gene Editing - Challenges and Future of CRISPR in Clinical Development
Gene Editing - Challenges and Future of CRISPR in Clinical DevelopmentGene Editing - Challenges and Future of CRISPR in Clinical Development
Gene Editing - Challenges and Future of CRISPR in Clinical Development
Medpace
 
Candidate Gene Approach in Crop Improvement
Candidate Gene Approach in Crop ImprovementCandidate Gene Approach in Crop Improvement
Candidate Gene Approach in Crop Improvement
BonipasAntony2
 
Emerging Clinical Applications of CRISPR-Cas9 as Promising Strategies in Gene...
Emerging Clinical Applications of CRISPR-Cas9 as Promising Strategies in Gene...Emerging Clinical Applications of CRISPR-Cas9 as Promising Strategies in Gene...
Emerging Clinical Applications of CRISPR-Cas9 as Promising Strategies in Gene...
Chi-Ping Day
 
The IMPACT of INDEL realignment: Detecting insertions and deletions longer th...
The IMPACT of INDEL realignment: Detecting insertions and deletions longer th...The IMPACT of INDEL realignment: Detecting insertions and deletions longer th...
The IMPACT of INDEL realignment: Detecting insertions and deletions longer th...
Ronak Shah
 
Detecting clinically actionable somatic structural aberrations from targeted ...
Detecting clinically actionable somatic structural aberrations from targeted ...Detecting clinically actionable somatic structural aberrations from targeted ...
Detecting clinically actionable somatic structural aberrations from targeted ...
Ronak Shah
 
MAGIC populations and its role in crop improvement
MAGIC populations and its role in crop improvementMAGIC populations and its role in crop improvement
MAGIC populations and its role in crop improvement
Dr. Asit Prasad Dash
 
Comparative analysis of gene regulation in mouse rat and human
Comparative analysis of gene regulation in mouse rat and humanComparative analysis of gene regulation in mouse rat and human
Comparative analysis of gene regulation in mouse rat and human
constantina mylona
 
Crispr Application
Crispr ApplicationCrispr Application
Crispr Application
Creative Biogene
 
RapportHicham
RapportHichamRapportHicham
RapportHicham
Hicham Janati
 
WrightPettibone_Austin_GeneDrives
WrightPettibone_Austin_GeneDrivesWrightPettibone_Austin_GeneDrives
WrightPettibone_Austin_GeneDrives
Austin Wright-Pettibone
 
CRISPR Gene Editing Congress, 25-27 February 2015 in Boston, MA
CRISPR Gene Editing Congress, 25-27 February 2015 in Boston, MACRISPR Gene Editing Congress, 25-27 February 2015 in Boston, MA
CRISPR Gene Editing Congress, 25-27 February 2015 in Boston, MA
Diane McKenna
 
High-Throughput Sequencing
High-Throughput SequencingHigh-Throughput Sequencing
High-Throughput Sequencing
Mark Pallen
 
Developing a framework for for detection of low frequency somatic genetic alt...
Developing a framework for for detection of low frequency somatic genetic alt...Developing a framework for for detection of low frequency somatic genetic alt...
Developing a framework for for detection of low frequency somatic genetic alt...
Ronak Shah
 
OKC Grand Rounds 2009
OKC Grand Rounds 2009OKC Grand Rounds 2009
OKC Grand Rounds 2009
Sean Davis
 
APPLICATION OF NEXT GENERATION SEQUENCING (NGS) IN CANCER TREATMENT
APPLICATION OF  NEXT GENERATION SEQUENCING (NGS)  IN CANCER TREATMENTAPPLICATION OF  NEXT GENERATION SEQUENCING (NGS)  IN CANCER TREATMENT
APPLICATION OF NEXT GENERATION SEQUENCING (NGS) IN CANCER TREATMENT
Dinie Fariz
 
Bioinformatics and NGS for advancing in hearing loss research
Bioinformatics and NGS for advancing in hearing loss researchBioinformatics and NGS for advancing in hearing loss research
Bioinformatics and NGS for advancing in hearing loss research
Joaquin Dopazo
 
Next generation sequencing in pharmacogenomics
Next generation sequencing in pharmacogenomicsNext generation sequencing in pharmacogenomics
Next generation sequencing in pharmacogenomics
Dr. Gerry Higgins
 
CRISPR Screening: the What, Why and How
CRISPR Screening: the What, Why and HowCRISPR Screening: the What, Why and How
CRISPR Screening: the What, Why and How
HorizonDiscovery
 

What's hot (20)

Comparison of LUMPY vs. DELLY for structural variant detection
Comparison of LUMPY vs. DELLY for structural variant detectionComparison of LUMPY vs. DELLY for structural variant detection
Comparison of LUMPY vs. DELLY for structural variant detection
 
MAGIC :Multiparent advanced generation intercross and QTL discovery
MAGIC :Multiparent advanced generation intercross and  QTL discovery MAGIC :Multiparent advanced generation intercross and  QTL discovery
MAGIC :Multiparent advanced generation intercross and QTL discovery
 
Gene Editing - Challenges and Future of CRISPR in Clinical Development
Gene Editing - Challenges and Future of CRISPR in Clinical DevelopmentGene Editing - Challenges and Future of CRISPR in Clinical Development
Gene Editing - Challenges and Future of CRISPR in Clinical Development
 
Candidate Gene Approach in Crop Improvement
Candidate Gene Approach in Crop ImprovementCandidate Gene Approach in Crop Improvement
Candidate Gene Approach in Crop Improvement
 
Emerging Clinical Applications of CRISPR-Cas9 as Promising Strategies in Gene...
Emerging Clinical Applications of CRISPR-Cas9 as Promising Strategies in Gene...Emerging Clinical Applications of CRISPR-Cas9 as Promising Strategies in Gene...
Emerging Clinical Applications of CRISPR-Cas9 as Promising Strategies in Gene...
 
The IMPACT of INDEL realignment: Detecting insertions and deletions longer th...
The IMPACT of INDEL realignment: Detecting insertions and deletions longer th...The IMPACT of INDEL realignment: Detecting insertions and deletions longer th...
The IMPACT of INDEL realignment: Detecting insertions and deletions longer th...
 
Detecting clinically actionable somatic structural aberrations from targeted ...
Detecting clinically actionable somatic structural aberrations from targeted ...Detecting clinically actionable somatic structural aberrations from targeted ...
Detecting clinically actionable somatic structural aberrations from targeted ...
 
MAGIC populations and its role in crop improvement
MAGIC populations and its role in crop improvementMAGIC populations and its role in crop improvement
MAGIC populations and its role in crop improvement
 
Comparative analysis of gene regulation in mouse rat and human
Comparative analysis of gene regulation in mouse rat and humanComparative analysis of gene regulation in mouse rat and human
Comparative analysis of gene regulation in mouse rat and human
 
Crispr Application
Crispr ApplicationCrispr Application
Crispr Application
 
RapportHicham
RapportHichamRapportHicham
RapportHicham
 
WrightPettibone_Austin_GeneDrives
WrightPettibone_Austin_GeneDrivesWrightPettibone_Austin_GeneDrives
WrightPettibone_Austin_GeneDrives
 
CRISPR Gene Editing Congress, 25-27 February 2015 in Boston, MA
CRISPR Gene Editing Congress, 25-27 February 2015 in Boston, MACRISPR Gene Editing Congress, 25-27 February 2015 in Boston, MA
CRISPR Gene Editing Congress, 25-27 February 2015 in Boston, MA
 
High-Throughput Sequencing
High-Throughput SequencingHigh-Throughput Sequencing
High-Throughput Sequencing
 
Developing a framework for for detection of low frequency somatic genetic alt...
Developing a framework for for detection of low frequency somatic genetic alt...Developing a framework for for detection of low frequency somatic genetic alt...
Developing a framework for for detection of low frequency somatic genetic alt...
 
OKC Grand Rounds 2009
OKC Grand Rounds 2009OKC Grand Rounds 2009
OKC Grand Rounds 2009
 
APPLICATION OF NEXT GENERATION SEQUENCING (NGS) IN CANCER TREATMENT
APPLICATION OF  NEXT GENERATION SEQUENCING (NGS)  IN CANCER TREATMENTAPPLICATION OF  NEXT GENERATION SEQUENCING (NGS)  IN CANCER TREATMENT
APPLICATION OF NEXT GENERATION SEQUENCING (NGS) IN CANCER TREATMENT
 
Bioinformatics and NGS for advancing in hearing loss research
Bioinformatics and NGS for advancing in hearing loss researchBioinformatics and NGS for advancing in hearing loss research
Bioinformatics and NGS for advancing in hearing loss research
 
Next generation sequencing in pharmacogenomics
Next generation sequencing in pharmacogenomicsNext generation sequencing in pharmacogenomics
Next generation sequencing in pharmacogenomics
 
CRISPR Screening: the What, Why and How
CRISPR Screening: the What, Why and HowCRISPR Screening: the What, Why and How
CRISPR Screening: the What, Why and How
 

Similar to Raj Lab Meeting May/01/2019

Population fitness and genetic load of
Population fitness and genetic load ofPopulation fitness and genetic load of
Population fitness and genetic load of
Thanka Elango
 
Population fitness and genetic load of
Population fitness and genetic load ofPopulation fitness and genetic load of
Population fitness and genetic load of
Thanka Elango
 
NAISTビッグデータシンポジウム - バイオ久保先生
NAISTビッグデータシンポジウム - バイオ久保先生NAISTビッグデータシンポジウム - バイオ久保先生
NAISTビッグデータシンポジウム - バイオ久保先生
ysuzuki-naist
 
Genomics Technologies
Genomics TechnologiesGenomics Technologies
Genomics Technologies
Sean Davis
 
R Gene Expression and Transcription Profiling
R Gene Expression and Transcription ProfilingR Gene Expression and Transcription Profiling
R Gene Expression and Transcription Profiling
Shraddha Karcho
 
Lecture bioinformatics Part2.next generation
Lecture bioinformatics Part2.next generationLecture bioinformatics Part2.next generation
Lecture bioinformatics Part2.next generation
MohamedHasan816582
 
A New Generation Of Mechanism-Based Biomarkers For The Clinic
A New Generation Of Mechanism-Based Biomarkers For The ClinicA New Generation Of Mechanism-Based Biomarkers For The Clinic
A New Generation Of Mechanism-Based Biomarkers For The Clinic
Joaquin Dopazo
 
Sept2016 plenary mercer_sequins
Sept2016 plenary mercer_sequinsSept2016 plenary mercer_sequins
Sept2016 plenary mercer_sequins
GenomeInABottle
 
Global Gene Expression Profiles from Breast Tumor Samples using the Ion Ampli...
Global Gene Expression Profiles from Breast Tumor Samples using the Ion Ampli...Global Gene Expression Profiles from Breast Tumor Samples using the Ion Ampli...
Global Gene Expression Profiles from Breast Tumor Samples using the Ion Ampli...
Thermo Fisher Scientific
 
ASHG 2015 - Redundant Annotations in Tertiary Analysis
ASHG 2015 - Redundant Annotations in Tertiary AnalysisASHG 2015 - Redundant Annotations in Tertiary Analysis
ASHG 2015 - Redundant Annotations in Tertiary Analysis
James Warren
 
gene_concept_2.pdf
gene_concept_2.pdfgene_concept_2.pdf
gene_concept_2.pdf
DarshanUmbarkar
 
21 kebere bezaweletaw 207-217
21 kebere bezaweletaw 207-21721 kebere bezaweletaw 207-217
21 kebere bezaweletaw 207-217
Alexander Decker
 
Genetic variation and its role in health pharmacology
Genetic variation and its role in health pharmacologyGenetic variation and its role in health pharmacology
Genetic variation and its role in health pharmacology
Deepak Kumar
 
Eshg poster roman-naranjo
Eshg poster roman-naranjoEshg poster roman-naranjo
Eshg poster roman-naranjo
Pablo Román-Naranjo Varela
 
Molecular Markers: Major Applications in Insects
Molecular Markers: Major Applications in InsectsMolecular Markers: Major Applications in Insects
Molecular Markers: Major Applications in Insects
Saramita De Chakravarti
 
Human genetic variation and its contribution to complex traits
Human genetic variation and its contribution to complex traitsHuman genetic variation and its contribution to complex traits
Human genetic variation and its contribution to complex traits
groovescience
 
Association mapping
Association mappingAssociation mapping
Association mapping
Senthil Natesan
 
RT-PCR and DNA microarray measurement of mRNA cell proliferation
RT-PCR and DNA microarray measurement of mRNA cell proliferationRT-PCR and DNA microarray measurement of mRNA cell proliferation
RT-PCR and DNA microarray measurement of mRNA cell proliferation
IJAEMSJORNAL
 
Gene expression group presentation at GAW 19
Gene expression group presentation at GAW 19Gene expression group presentation at GAW 19
Gene expression group presentation at GAW 19
Francesco Gadaleta
 
14KoVar
14KoVar14KoVar

Similar to Raj Lab Meeting May/01/2019 (20)

Population fitness and genetic load of
Population fitness and genetic load ofPopulation fitness and genetic load of
Population fitness and genetic load of
 
Population fitness and genetic load of
Population fitness and genetic load ofPopulation fitness and genetic load of
Population fitness and genetic load of
 
NAISTビッグデータシンポジウム - バイオ久保先生
NAISTビッグデータシンポジウム - バイオ久保先生NAISTビッグデータシンポジウム - バイオ久保先生
NAISTビッグデータシンポジウム - バイオ久保先生
 
Genomics Technologies
Genomics TechnologiesGenomics Technologies
Genomics Technologies
 
R Gene Expression and Transcription Profiling
R Gene Expression and Transcription ProfilingR Gene Expression and Transcription Profiling
R Gene Expression and Transcription Profiling
 
Lecture bioinformatics Part2.next generation
Lecture bioinformatics Part2.next generationLecture bioinformatics Part2.next generation
Lecture bioinformatics Part2.next generation
 
A New Generation Of Mechanism-Based Biomarkers For The Clinic
A New Generation Of Mechanism-Based Biomarkers For The ClinicA New Generation Of Mechanism-Based Biomarkers For The Clinic
A New Generation Of Mechanism-Based Biomarkers For The Clinic
 
Sept2016 plenary mercer_sequins
Sept2016 plenary mercer_sequinsSept2016 plenary mercer_sequins
Sept2016 plenary mercer_sequins
 
Global Gene Expression Profiles from Breast Tumor Samples using the Ion Ampli...
Global Gene Expression Profiles from Breast Tumor Samples using the Ion Ampli...Global Gene Expression Profiles from Breast Tumor Samples using the Ion Ampli...
Global Gene Expression Profiles from Breast Tumor Samples using the Ion Ampli...
 
ASHG 2015 - Redundant Annotations in Tertiary Analysis
ASHG 2015 - Redundant Annotations in Tertiary AnalysisASHG 2015 - Redundant Annotations in Tertiary Analysis
ASHG 2015 - Redundant Annotations in Tertiary Analysis
 
gene_concept_2.pdf
gene_concept_2.pdfgene_concept_2.pdf
gene_concept_2.pdf
 
21 kebere bezaweletaw 207-217
21 kebere bezaweletaw 207-21721 kebere bezaweletaw 207-217
21 kebere bezaweletaw 207-217
 
Genetic variation and its role in health pharmacology
Genetic variation and its role in health pharmacologyGenetic variation and its role in health pharmacology
Genetic variation and its role in health pharmacology
 
Eshg poster roman-naranjo
Eshg poster roman-naranjoEshg poster roman-naranjo
Eshg poster roman-naranjo
 
Molecular Markers: Major Applications in Insects
Molecular Markers: Major Applications in InsectsMolecular Markers: Major Applications in Insects
Molecular Markers: Major Applications in Insects
 
Human genetic variation and its contribution to complex traits
Human genetic variation and its contribution to complex traitsHuman genetic variation and its contribution to complex traits
Human genetic variation and its contribution to complex traits
 
Association mapping
Association mappingAssociation mapping
Association mapping
 
RT-PCR and DNA microarray measurement of mRNA cell proliferation
RT-PCR and DNA microarray measurement of mRNA cell proliferationRT-PCR and DNA microarray measurement of mRNA cell proliferation
RT-PCR and DNA microarray measurement of mRNA cell proliferation
 
Gene expression group presentation at GAW 19
Gene expression group presentation at GAW 19Gene expression group presentation at GAW 19
Gene expression group presentation at GAW 19
 
14KoVar
14KoVar14KoVar
14KoVar
 

Recently uploaded

Suzanne Lagerweij - Influence Without Power - Why Empathy is Your Best Friend...
Suzanne Lagerweij - Influence Without Power - Why Empathy is Your Best Friend...Suzanne Lagerweij - Influence Without Power - Why Empathy is Your Best Friend...
Suzanne Lagerweij - Influence Without Power - Why Empathy is Your Best Friend...
Suzanne Lagerweij
 
The Intersection between Competition and Data Privacy – COLANGELO – June 2024...
The Intersection between Competition and Data Privacy – COLANGELO – June 2024...The Intersection between Competition and Data Privacy – COLANGELO – June 2024...
The Intersection between Competition and Data Privacy – COLANGELO – June 2024...
OECD Directorate for Financial and Enterprise Affairs
 
2024-05-30_meetup_devops_aix-marseille.pdf
2024-05-30_meetup_devops_aix-marseille.pdf2024-05-30_meetup_devops_aix-marseille.pdf
2024-05-30_meetup_devops_aix-marseille.pdf
Frederic Leger
 
XP 2024 presentation: A New Look to Leadership
XP 2024 presentation: A New Look to LeadershipXP 2024 presentation: A New Look to Leadership
XP 2024 presentation: A New Look to Leadership
samililja
 
Artificial Intelligence, Data and Competition – LIM – June 2024 OECD discussion
Artificial Intelligence, Data and Competition – LIM – June 2024 OECD discussionArtificial Intelligence, Data and Competition – LIM – June 2024 OECD discussion
Artificial Intelligence, Data and Competition – LIM – June 2024 OECD discussion
OECD Directorate for Financial and Enterprise Affairs
 
Gregory Harris - Cycle 2 - Civics Presentation
Gregory Harris - Cycle 2 - Civics PresentationGregory Harris - Cycle 2 - Civics Presentation
Gregory Harris - Cycle 2 - Civics Presentation
gharris9
 
The Intersection between Competition and Data Privacy – KEMP – June 2024 OECD...
The Intersection between Competition and Data Privacy – KEMP – June 2024 OECD...The Intersection between Competition and Data Privacy – KEMP – June 2024 OECD...
The Intersection between Competition and Data Privacy – KEMP – June 2024 OECD...
OECD Directorate for Financial and Enterprise Affairs
 
Carrer goals.pptx and their importance in real life
Carrer goals.pptx  and their importance in real lifeCarrer goals.pptx  and their importance in real life
Carrer goals.pptx and their importance in real life
artemacademy2
 
Competition and Regulation in Professions and Occupations – OECD – June 2024 ...
Competition and Regulation in Professions and Occupations – OECD – June 2024 ...Competition and Regulation in Professions and Occupations – OECD – June 2024 ...
Competition and Regulation in Professions and Occupations – OECD – June 2024 ...
OECD Directorate for Financial and Enterprise Affairs
 
Artificial Intelligence, Data and Competition – SCHREPEL – June 2024 OECD dis...
Artificial Intelligence, Data and Competition – SCHREPEL – June 2024 OECD dis...Artificial Intelligence, Data and Competition – SCHREPEL – June 2024 OECD dis...
Artificial Intelligence, Data and Competition – SCHREPEL – June 2024 OECD dis...
OECD Directorate for Financial and Enterprise Affairs
 
Artificial Intelligence, Data and Competition – ČORBA – June 2024 OECD discus...
Artificial Intelligence, Data and Competition – ČORBA – June 2024 OECD discus...Artificial Intelligence, Data and Competition – ČORBA – June 2024 OECD discus...
Artificial Intelligence, Data and Competition – ČORBA – June 2024 OECD discus...
OECD Directorate for Financial and Enterprise Affairs
 
Pro-competitive Industrial Policy – LANE – June 2024 OECD discussion
Pro-competitive Industrial Policy – LANE – June 2024 OECD discussionPro-competitive Industrial Policy – LANE – June 2024 OECD discussion
Pro-competitive Industrial Policy – LANE – June 2024 OECD discussion
OECD Directorate for Financial and Enterprise Affairs
 
Pro-competitive Industrial Policy – OECD – June 2024 OECD discussion
Pro-competitive Industrial Policy – OECD – June 2024 OECD discussionPro-competitive Industrial Policy – OECD – June 2024 OECD discussion
Pro-competitive Industrial Policy – OECD – June 2024 OECD discussion
OECD Directorate for Financial and Enterprise Affairs
 
Using-Presentation-Software-to-the-Fullf.pptx
Using-Presentation-Software-to-the-Fullf.pptxUsing-Presentation-Software-to-the-Fullf.pptx
Using-Presentation-Software-to-the-Fullf.pptx
kainatfatyma9
 
BRIC_2024_2024-06-06-11:30-haunschild_archival_version.pdf
BRIC_2024_2024-06-06-11:30-haunschild_archival_version.pdfBRIC_2024_2024-06-06-11:30-haunschild_archival_version.pdf
BRIC_2024_2024-06-06-11:30-haunschild_archival_version.pdf
Robin Haunschild
 
The Intersection between Competition and Data Privacy – CAPEL – June 2024 OEC...
The Intersection between Competition and Data Privacy – CAPEL – June 2024 OEC...The Intersection between Competition and Data Privacy – CAPEL – June 2024 OEC...
The Intersection between Competition and Data Privacy – CAPEL – June 2024 OEC...
OECD Directorate for Financial and Enterprise Affairs
 
Competition and Regulation in Professions and Occupations – ROBSON – June 202...
Competition and Regulation in Professions and Occupations – ROBSON – June 202...Competition and Regulation in Professions and Occupations – ROBSON – June 202...
Competition and Regulation in Professions and Occupations – ROBSON – June 202...
OECD Directorate for Financial and Enterprise Affairs
 
ASONAM2023_presection_slide_track-recommendation.pdf
ASONAM2023_presection_slide_track-recommendation.pdfASONAM2023_presection_slide_track-recommendation.pdf
ASONAM2023_presection_slide_track-recommendation.pdf
ToshihiroIto4
 
The remarkable life of Sir Mokshagundam Visvesvaraya.pptx
The remarkable life of Sir Mokshagundam Visvesvaraya.pptxThe remarkable life of Sir Mokshagundam Visvesvaraya.pptx
The remarkable life of Sir Mokshagundam Visvesvaraya.pptx
JiteshKumarChoudhary2
 
Artificial Intelligence, Data and Competition – OECD – June 2024 OECD discussion
Artificial Intelligence, Data and Competition – OECD – June 2024 OECD discussionArtificial Intelligence, Data and Competition – OECD – June 2024 OECD discussion
Artificial Intelligence, Data and Competition – OECD – June 2024 OECD discussion
OECD Directorate for Financial and Enterprise Affairs
 

Recently uploaded (20)

Suzanne Lagerweij - Influence Without Power - Why Empathy is Your Best Friend...
Suzanne Lagerweij - Influence Without Power - Why Empathy is Your Best Friend...Suzanne Lagerweij - Influence Without Power - Why Empathy is Your Best Friend...
Suzanne Lagerweij - Influence Without Power - Why Empathy is Your Best Friend...
 
The Intersection between Competition and Data Privacy – COLANGELO – June 2024...
The Intersection between Competition and Data Privacy – COLANGELO – June 2024...The Intersection between Competition and Data Privacy – COLANGELO – June 2024...
The Intersection between Competition and Data Privacy – COLANGELO – June 2024...
 
2024-05-30_meetup_devops_aix-marseille.pdf
2024-05-30_meetup_devops_aix-marseille.pdf2024-05-30_meetup_devops_aix-marseille.pdf
2024-05-30_meetup_devops_aix-marseille.pdf
 
XP 2024 presentation: A New Look to Leadership
XP 2024 presentation: A New Look to LeadershipXP 2024 presentation: A New Look to Leadership
XP 2024 presentation: A New Look to Leadership
 
Artificial Intelligence, Data and Competition – LIM – June 2024 OECD discussion
Artificial Intelligence, Data and Competition – LIM – June 2024 OECD discussionArtificial Intelligence, Data and Competition – LIM – June 2024 OECD discussion
Artificial Intelligence, Data and Competition – LIM – June 2024 OECD discussion
 
Gregory Harris - Cycle 2 - Civics Presentation
Gregory Harris - Cycle 2 - Civics PresentationGregory Harris - Cycle 2 - Civics Presentation
Gregory Harris - Cycle 2 - Civics Presentation
 
The Intersection between Competition and Data Privacy – KEMP – June 2024 OECD...
The Intersection between Competition and Data Privacy – KEMP – June 2024 OECD...The Intersection between Competition and Data Privacy – KEMP – June 2024 OECD...
The Intersection between Competition and Data Privacy – KEMP – June 2024 OECD...
 
Carrer goals.pptx and their importance in real life
Carrer goals.pptx  and their importance in real lifeCarrer goals.pptx  and their importance in real life
Carrer goals.pptx and their importance in real life
 
Competition and Regulation in Professions and Occupations – OECD – June 2024 ...
Competition and Regulation in Professions and Occupations – OECD – June 2024 ...Competition and Regulation in Professions and Occupations – OECD – June 2024 ...
Competition and Regulation in Professions and Occupations – OECD – June 2024 ...
 
Artificial Intelligence, Data and Competition – SCHREPEL – June 2024 OECD dis...
Artificial Intelligence, Data and Competition – SCHREPEL – June 2024 OECD dis...Artificial Intelligence, Data and Competition – SCHREPEL – June 2024 OECD dis...
Artificial Intelligence, Data and Competition – SCHREPEL – June 2024 OECD dis...
 
Artificial Intelligence, Data and Competition – ČORBA – June 2024 OECD discus...
Artificial Intelligence, Data and Competition – ČORBA – June 2024 OECD discus...Artificial Intelligence, Data and Competition – ČORBA – June 2024 OECD discus...
Artificial Intelligence, Data and Competition – ČORBA – June 2024 OECD discus...
 
Pro-competitive Industrial Policy – LANE – June 2024 OECD discussion
Pro-competitive Industrial Policy – LANE – June 2024 OECD discussionPro-competitive Industrial Policy – LANE – June 2024 OECD discussion
Pro-competitive Industrial Policy – LANE – June 2024 OECD discussion
 
Pro-competitive Industrial Policy – OECD – June 2024 OECD discussion
Pro-competitive Industrial Policy – OECD – June 2024 OECD discussionPro-competitive Industrial Policy – OECD – June 2024 OECD discussion
Pro-competitive Industrial Policy – OECD – June 2024 OECD discussion
 
Using-Presentation-Software-to-the-Fullf.pptx
Using-Presentation-Software-to-the-Fullf.pptxUsing-Presentation-Software-to-the-Fullf.pptx
Using-Presentation-Software-to-the-Fullf.pptx
 
BRIC_2024_2024-06-06-11:30-haunschild_archival_version.pdf
BRIC_2024_2024-06-06-11:30-haunschild_archival_version.pdfBRIC_2024_2024-06-06-11:30-haunschild_archival_version.pdf
BRIC_2024_2024-06-06-11:30-haunschild_archival_version.pdf
 
The Intersection between Competition and Data Privacy – CAPEL – June 2024 OEC...
The Intersection between Competition and Data Privacy – CAPEL – June 2024 OEC...The Intersection between Competition and Data Privacy – CAPEL – June 2024 OEC...
The Intersection between Competition and Data Privacy – CAPEL – June 2024 OEC...
 
Competition and Regulation in Professions and Occupations – ROBSON – June 202...
Competition and Regulation in Professions and Occupations – ROBSON – June 202...Competition and Regulation in Professions and Occupations – ROBSON – June 202...
Competition and Regulation in Professions and Occupations – ROBSON – June 202...
 
ASONAM2023_presection_slide_track-recommendation.pdf
ASONAM2023_presection_slide_track-recommendation.pdfASONAM2023_presection_slide_track-recommendation.pdf
ASONAM2023_presection_slide_track-recommendation.pdf
 
The remarkable life of Sir Mokshagundam Visvesvaraya.pptx
The remarkable life of Sir Mokshagundam Visvesvaraya.pptxThe remarkable life of Sir Mokshagundam Visvesvaraya.pptx
The remarkable life of Sir Mokshagundam Visvesvaraya.pptx
 
Artificial Intelligence, Data and Competition – OECD – June 2024 OECD discussion
Artificial Intelligence, Data and Competition – OECD – June 2024 OECD discussionArtificial Intelligence, Data and Competition – OECD – June 2024 OECD discussion
Artificial Intelligence, Data and Competition – OECD – June 2024 OECD discussion
 

Raj Lab Meeting May/01/2019

  • 1. The impact of rare variation on gene expression across tissues Katia Lopes, PhD Ricardo Vialle, PhD Raj Lab Department of Neurosciences May 1st 2019
  • 2.
  • 3. Background Currently is hard to distinguish pathogenic from benign rare non- coding variants Association studies (like GWAS) usually works fine for common variants, however they are not practical for rare variants (large sample sizes are required) Analyzing the effect of rare non-coding variants in the expression across different tissues may help to elucidate their roles in diseases!
  • 4. GTEx project v6p release RNA-seq + Whole-genome sequencing (WGS) 449 individuals 44 tissues log2(RPKM + 2) Allele-specific expression (ASE) Gencode v.19 annotation Protein coding genes + long intergenic noncoding RNAs (lincRNA) Estimated hidden factors using PEER Standardized the expression for each gene with Z-scores Data
  • 5. PEER correction Total expression removed by PEER A noticeable difference between the brain and other tissues ??? Linear Regression between the covariate values and the PEER factors White = missing values
  • 6. Outlier definition Focus: Individuals with extremely high or extremely low expression of a particular gene compared with the population OUTLIERS |Z-score| >= 2 AKR1C4 Single-tissue outlier Single-tissue outlier Single-tissue outlier Multi-tissue outlier At least 5 tissues For each gene… e.g. Pair Gene + Individual
  • 7. Multi-tissue outlier distribution Ext Fig 2 - Distribution of the number of genes with a multi-tissue outlier. a, Each individual was an outlier for a median of 10 genes. Individuals with 50 or more outliers are colored in grey and were excluded from downstream analyses. b – c, Distribution of the number of genes for which individuals, stratified by common covariates, were multi-tissue outliers. Number of genes Multi-tissue outliers
  • 8. GTEx 449 individuals 44 tissues 10 brain tissues 18,830 genes tested b, Outlier expression sharing between tissues measured by the proportion of single-tissue outliers that have a |Z- score| >= 2 Single tissue outlier
  • 9. Replication of expression outliers 2 groups of expression data: Discovery set of 34 tissues Replication set of 10 tissues For t = 10, 15, 20, 25 and 30 Multi-tissue outlier replication Replication = 60% | Z-score >=1 Replication = ~30% | Z-score >=2
  • 10. In order to investigate the influence of rare genetic variation on extreme expression levels they focused on individuals of European ancestry with WGS data (1,144 multi-tissue outliers) Autosomal variants that passed all filters in the VCF (PASS in the filter column) Rare variants were defined as having MAF ≤ 0.01 in GTEx SNVs and indels with MAF ≤ 0.01 in the European population of the 1000 Genomes Project Phase 3 data They checked if the allele frequency was similar in the 1000 Genome Project Rare genetic variation
  • 11. Multi-tissue outliers were strongly enriched for nearby rare variants. The enrichment was most pronounced for structural variants (SV) and greater for short insertions and deletions (indels) than for single-nucleotide variants (SNVs) Enrichment of rare variants in outliers Figure 2 | Enrichment of rare variants and allele-specific expression (ASE) in outliers. a, Enrichment within 10 kb of the transcription start site (TSS) among outliers. Rare Common 1144 multi-tissue outlier (WGS) Y = Enrichment as the relative risk of having a nearby rare variant
  • 12. Figure 2 | Enrichment of rare variants and allele-specific expression (ASE) in outliers. b, Rare SNV enrichments at increasing Z-score thresholds. Rare genetic variation
  • 13. Under vs Over expressed outliers
  • 14. Under vs Over expressed outliersAllele-specificexpression(ASE)
  • 15. Figure 3 | Stratification of multi-tissue outliers by rare variant classes.
  • 16. RIVER (RNA-informed variant effect on regulation) A Bayesian statistical model that jointly analyses genome and transcriptome data from the same individual to estimate the probability that a variant has regulatory impact! Software - RIVER Roadmap Epigenomics CADD VEP F = binary variable representing the functional regulatory status of the rare variant E = binary node representing expression outlier status
  • 17. Software: RIVER Figure 5 | Performance of RIVER for prioritizing functional regulatory variants. b, Predictive power of RIVER compared to an L2-regularized logistic regression model using only genomic annotations. 3.766 pairs shared by 2 individuals Computes test posterior probabilities of FR for 1st individual, and compares them with outlier status of 2nd individual from the list
  • 18. Software: RIVER Figure 5 | Performance of RIVER for prioritizing functional regulatory variants. c, Distribution of RIVER scores as a function of expression and genomic annotation scores.
  • 20. GAMT is associated with cerebral creatine deficiency syndrome 2, and causes neurological deficiencies and also lead to low body fat SBDS is associated with the recessive Shwachman–Diamond syndrome Software: RIVER
  • 21. Applications for Raj Lab 1. Correlate factors with covariates (PEER, PCA … ) 2. Z-scores for gene-individual outlier detection 3. Enrichment of rare variants near outliers 4. Use RIVER to prioritize rare variants in each individual genome by their predicted impact on gene expression 5. Single vs Multi-tissue data (or multi cell types?)